1996
DOI: 10.1159/000473834
|View full text |Cite
|
Sign up to set email alerts
|

The Risks Outweigh the Benefits of Radical Prostatectomy in Localised Prostate Cancer: The Argument For

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
0
0
1

Year Published

1997
1997
2006
2006

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
1
0
0
1
Order By: Relevance
“…This might be due to epidemiological data such as that from the USA showing declining mortality from prostate cancer, which had been attributed to increased screening [8]. The choice between surgery or radiotherapy for early, localized disease was unchanged between 1995 and 2000; most clinicians preferred surgery in a relatively young man and radiotherapy or observation in the older man, consistent with other studies [4,9,10]. We were surprised by the increased use of neoadjuvant and adjuvant hormonal therapy for patients receiving radiotherapy for early‐stage disease.…”
Section: Discussionsupporting
confidence: 64%
“…This might be due to epidemiological data such as that from the USA showing declining mortality from prostate cancer, which had been attributed to increased screening [8]. The choice between surgery or radiotherapy for early, localized disease was unchanged between 1995 and 2000; most clinicians preferred surgery in a relatively young man and radiotherapy or observation in the older man, consistent with other studies [4,9,10]. We were surprised by the increased use of neoadjuvant and adjuvant hormonal therapy for patients receiving radiotherapy for early‐stage disease.…”
Section: Discussionsupporting
confidence: 64%
“…Por ello, los pacientes jóvenes con una esperanza de vida de más de 15 años es de esperar que se beneficien de cirugía radical. Mientras que estos pacientes de menor edad, se ha visto peor comportamiento tumoral como resultado de la radioterapia Y por el lado opuesto, el tratamiento conservador es una opción válida para pacientes por encima de los 70 años con cánceres de bajo grado, clínicamente localizados en la próstata y con una esperanza de vida menor de 10 años [373].…”
Section: )unclassified